ARYA Sciences Acquisition Corp. IV (ARYD)

NASDAQ: ARYD · IEX Real-Time Price · USD
-0.01 (-0.10%)
Dec 5, 2022 4:30 PM EST - Market closed
Market Cap 192.82M
Revenue (ttm) n/a
Net Income (ttm) 1.68M
Shares Out 19.19M
EPS (ttm) 0.09
PE Ratio 111.56
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,300
Open 10.04
Previous Close 10.05
Day's Range 10.04 - 10.04
52-Week Range 9.7 - 10.05
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ARYD

ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. [Read more]

Industry Blank Check / SPAC
IPO Date Feb 26, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol ARYD
Full Company Profile

Financial Performance

Financial Statements


ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agre...

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announced...

9 months ago - GlobeNewsWire